Nandan Padukone

Chief Executive Officer at ImmunoMolecular Therapeutics, Inc.

Health Technology

Profile

Nandan Padukone is currently the Chief Executive Officer at ImmunoMolecular Therapeutics, Inc. Prior to this, he worked as the Senior Vice President-Innovations at Joslin Diabetes Center, Inc.

Nandan Padukone active positions

Companies	Position	Start
ImmunoMolecular Therapeutics, Inc. ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO.	Chief Executive Officer	-

All active positions of Nandan Padukone

Former positions of Nandan Padukone

Companies	Position	End
Joslin Diabetes Center, Inc. Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA.	Corporate Officer/Principal	1990-01-01

See the detail of Nandan Padukone's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nandan Padukone's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Joslin Diabetes Center, Inc. Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA.	Health Technology
ImmunoMolecular Therapeutics, Inc. ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO.	Health Technology